[go: up one dir, main page]

EE200200282A - Keemilised meetodid ja vaheühendid - Google Patents

Keemilised meetodid ja vaheühendid

Info

Publication number
EE200200282A
EE200200282A EEP200200282A EEP200200282A EE200200282A EE 200200282 A EE200200282 A EE 200200282A EE P200200282 A EEP200200282 A EE P200200282A EE P200200282 A EEP200200282 A EE P200200282A EE 200200282 A EE200200282 A EE 200200282A
Authority
EE
Estonia
Prior art keywords
intermediates
chemical methods
chemical
methods
Prior art date
Application number
EEP200200282A
Other languages
English (en)
Estonian (et)
Inventor
Barry Gravestock Michael
Edwin Herbert Warren Kenneth
Simon Ennis David
Charlotte Currie Angela
Ainge Debra
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of EE200200282A publication Critical patent/EE200200282A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574—Esters of oxyacids of phosphorus
    • C07F9/65742—Esters of oxyacids of phosphorus non-condensed with carbocyclic rings or heterocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
EEP200200282A 1999-12-03 2000-11-28 Keemilised meetodid ja vaheühendid EE200200282A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9928499.4A GB9928499D0 (en) 1999-12-03 1999-12-03 Chemical processes and intermediates
PCT/GB2000/004527 WO2001040236A2 (en) 1999-12-03 2000-11-28 Phosphorylation of terminal primary alcohol groups

Publications (1)

Publication Number Publication Date
EE200200282A true EE200200282A (et) 2003-06-16

Family

ID=10865576

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200282A EE200200282A (et) 1999-12-03 2000-11-28 Keemilised meetodid ja vaheühendid

Country Status (22)

Country Link
EP (1) EP1237895A2 (xx)
JP (1) JP2003515539A (xx)
KR (1) KR20020058072A (xx)
CN (1) CN1433421A (xx)
AR (1) AR026700A1 (xx)
AU (1) AU762241B2 (xx)
BG (1) BG106728A (xx)
BR (1) BR0016087A (xx)
CA (1) CA2395052A1 (xx)
CO (1) CO5271712A1 (xx)
CZ (1) CZ20021912A3 (xx)
EE (1) EE200200282A (xx)
GB (1) GB9928499D0 (xx)
HU (1) HUP0204052A2 (xx)
IL (1) IL149641A0 (xx)
IS (1) IS6401A (xx)
MX (1) MXPA02005396A (xx)
NO (1) NO20022605L (xx)
PL (1) PL364762A1 (xx)
SK (1) SK7862002A3 (xx)
WO (1) WO2001040236A2 (xx)
ZA (1) ZA200203876B (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
GB0113297D0 (en) * 2001-06-01 2001-07-25 Astrazeneca Ab Chemical Process
WO2003022824A1 (en) 2001-09-11 2003-03-20 Astrazeneca Ab Oxazolidinone and/or isoxazoline as antibacterial agents
JP2005512975A (ja) 2001-10-25 2005-05-12 アストラゼネカ アクチボラグ 抗菌薬として有用なイソキサゾリン誘導体
AR038536A1 (es) 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
US7141588B2 (en) 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
PL372191A1 (en) 2002-02-28 2005-07-11 Astrazeneca Ab 3-cyclyl-5-(nitrogen-containing 5-membered ring) methyl-oxazolidinone derivatives and their use as antibacterial agents
CN1653064A (zh) 2002-02-28 2005-08-10 阿斯特拉曾尼卡有限公司 噁唑烷酮衍生物、其制备方法以及包含它们的药用组合物
CA2491287A1 (en) 2002-08-12 2004-02-19 Pharmacia & Upjohn Company N-aryl-2-oxazolidinones and their derivatives
US7091196B2 (en) 2002-09-26 2006-08-15 Rib-X Pharmaceuticals, Inc. Bifunctional heterocyclic compounds and methods of making and using same
ATE344036T1 (de) 2002-11-21 2006-11-15 Pharmacia & Upjohn Co Llc N-(4-(piperazin-1-yl)-phenyl-2-oxazolidinon-5- carbonsäureamid-derivate und verwandte verbindungen als antibakterielle mittel
TWI454465B (zh) 2003-06-03 2014-10-01 Melinta Therapeutics Inc 聯芳基雜環化合物及製法及其用途
US8324398B2 (en) 2003-06-03 2012-12-04 Rib-X Pharmaceuticals, Inc. Process for the synthesis of biaryl oxazolidinones
US7304050B2 (en) 2003-09-16 2007-12-04 Pfizer Inc. Antibacterial agents
EP1713785A1 (en) 2003-12-17 2006-10-25 Rib-X Pharmaceuticals, Inc. Halogenated biaryl heterocyclic compounds and methods of making and using the same
US8202843B2 (en) 2004-02-27 2012-06-19 Rib-X Pharmaceuticals, Inc. Macrocyclic compounds and methods of making and using the same
ATE496914T1 (de) 2005-06-08 2011-02-15 Rib X Pharmaceuticals Inc Verfahren zur synthese von triazolen
KR20130095850A (ko) * 2006-09-25 2013-08-28 욱크하르트 리미티드 치환된 피페리디노페닐 옥사졸리디논
US9572809B2 (en) 2012-07-18 2017-02-21 Spero Trinem, Inc. Combination therapy to treat Mycobacterium diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID30299A (id) * 1998-06-05 2001-11-22 Astrazeneca Ab Turunan oksazolidinon, proses pembuatannya dan komposisi farmasi yang mengandungnya

Also Published As

Publication number Publication date
WO2001040236A3 (en) 2002-05-10
KR20020058072A (ko) 2002-07-12
MXPA02005396A (es) 2002-11-29
EP1237895A2 (en) 2002-09-11
GB9928499D0 (en) 2000-02-02
BR0016087A (pt) 2002-08-06
HUP0204052A2 (hu) 2003-03-28
IS6401A (is) 2002-05-28
JP2003515539A (ja) 2003-05-07
CN1433421A (zh) 2003-07-30
SK7862002A3 (en) 2003-02-04
IL149641A0 (en) 2002-11-10
AR026700A1 (es) 2003-02-26
WO2001040236A2 (en) 2001-06-07
CA2395052A1 (en) 2001-06-07
CZ20021912A3 (cs) 2002-08-14
NO20022605L (no) 2002-06-26
PL364762A1 (en) 2004-12-13
AU1715601A (en) 2001-06-12
ZA200203876B (en) 2003-08-15
NO20022605D0 (no) 2002-05-31
AU762241B2 (en) 2003-06-19
BG106728A (en) 2003-02-28
CO5271712A1 (es) 2003-04-30

Similar Documents

Publication Publication Date Title
DE60019547D1 (de) Biosensor
DE60018541D1 (de) Biosensor
EP1156325A4 (en) BIOSENSOR
EP1182450A4 (en) BIOSENSOR
DE60036746D1 (de) Analysator
EE200200282A (et) Keemilised meetodid ja vaheühendid
DK1185536T3 (da) Hemisyntesefremgangsmåde og mellemprodukter deraf
ID26056A (id) Popok sekali pakai
ID26389A (id) Popok sekali pakai
ID25571A (id) Popok sekali pakai
ID24782A (id) Popok sekali pakai
NO20021604L (no) Leptin assay
DE50005753D1 (de) Montageverfahren
ID30381A (id) Penggunaan arilalkanoilpiridazina
DE60044052D1 (de) Pyrolytisches Analyseverfahren
EP0986747A4 (en) Improved biosensor
FI20040019L (fi) Kemiallinen koostumus ja menetelmä
PT1232141E (pt) Eteres de o-desmetil-venlafaxina
ATA213799A (de) Gebäude
ATA203199A (de) Ablauf
ES1042932Y (es) Inyector-reactor biologico
ATA4098A (de) Tragkonstruktion
SE9903962D0 (sv) Ny användning
SE9901136D0 (sv) Ny användning
NO20015444L (no) Ny fremgangsmåte